| http://www.w3.org/ns/prov#value | - s, based in the United States, could be interested.Additionally, private equity firms such as Cinven, Carlyle, Permira and Bain Capital could be in the frame to do a deal.Rexam chief executive Graham Chipchase told analysts earlier this month that the healthcare arm, which recently reported 23 million pounds of half year underlying pre-tax profit on sales of 224 million pounds, was attracting lots
|
